These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10771016)

  • 1. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.
    Perry E; Martin-Ruiz C; Lee M; Griffiths M; Johnson M; Piggott M; Haroutunian V; Buxbaum JD; Nãsland J; Davis K; Gotti C; Clementi F; Tzartos S; Cohen O; Soreq H; Jaros E; Perry R; Ballard C; McKeith I; Court J
    Eur J Pharmacol; 2000 Mar; 393(1-3):215-22. PubMed ID: 10771016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
    Perry EK; Morris CM; Court JA; Cheng A; Fairbairn AF; McKeith IG; Irving D; Brown A; Perry RH
    Neuroscience; 1995 Jan; 64(2):385-95. PubMed ID: 7700528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic receptor subtypes in human brain related to aging and dementia.
    Perry EK; Martin-Ruiz CM; Court JA
    Alcohol; 2001 Jun; 24(2):63-8. PubMed ID: 11522424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain.
    Hellström-Lindahl E; Mousavi M; Zhang X; Ravid R; Nordberg A
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):94-103. PubMed ID: 10095081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
    Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK
    Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective changes in expression of different nicotinic receptor subtypes in brain and adrenal glands of mice carrying human mutated gene for APP or over-expressing human acetylcholinestrase.
    Mousavi M; Bednar I; Nordberg A
    Int J Dev Neurosci; 2004 Nov; 22(7):545-9. PubMed ID: 15465284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.
    Martin-Ruiz CM; Court JA; Molnar E; Lee M; Gotti C; Mamalaki A; Tsouloufis T; Tzartos S; Ballard C; Perry RH; Perry EK
    J Neurochem; 1999 Oct; 73(4):1635-40. PubMed ID: 10501210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types.
    Martin-Ruiz C; Court J; Lee M; Piggott M; Johnson M; Ballard C; Kalaria R; Perry R; Perry E
    Acta Neurol Scand Suppl; 2000; 176():34-41. PubMed ID: 11261803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease.
    Mousavi M; Hellström-Lindahl E; Guan ZZ; Shan KR; Ravid R; Nordberg A
    Neuroscience; 2003; 122(2):515-20. PubMed ID: 14614915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.
    Pimlott SL; Piggott M; Owens J; Greally E; Court JA; Jaros E; Perry RH; Perry EK; Wyper D
    Neuropsychopharmacology; 2004 Jan; 29(1):108-16. PubMed ID: 12955099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
    J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes.
    Teaktong T; Graham A; Court J; Perry R; Jaros E; Johnson M; Hall R; Perry E
    Glia; 2003 Jan; 41(2):207-11. PubMed ID: 12509811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase.
    Svedberg MM; Svensson AL; Johnson M; Lee M; Cohen O; Court J; Soreq H; Perry E; Nordberg A
    J Mol Neurosci; 2002 Jun; 18(3):211-22. PubMed ID: 12059039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer's disease.
    Rei RT; Sabbagh MN; Corey-Bloom J; Tiraboschi P; Thal LJ
    Neurobiol Aging; 2000; 21(5):741-6. PubMed ID: 11016544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
    Marks MJ; Whiteaker P; Collins AC
    Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.
    Gotti C; Moretti M; Bohr I; Ziabreva I; Vailati S; Longhi R; Riganti L; Gaimarri A; McKeith IG; Perry RH; Aarsland D; Larsen JP; Sher E; Beattie R; Clementi F; Court JA
    Neurobiol Dis; 2006 Aug; 23(2):481-9. PubMed ID: 16759874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M; Hellström-Lindahl E
    Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
    Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease.
    Guan ZZ; Nordberg A; Mousavi M; Rinne JO; Hellström-Lindahl E
    Brain Res; 2002 Nov; 956(2):358-66. PubMed ID: 12445706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease.
    Martin-Ruiz CM; Piggott M; Gotti C; Lindstrom J; Mendelow AD; Siddique MS; Perry RH; Perry EK; Court JA
    Neuropharmacology; 2000 Oct; 39(13):2830-9. PubMed ID: 11044753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.